Site-Specific In-111-Radiolabeling of Dual-PEGylated Porous Silicon Nanoparticles and Their In Vivo Evaluation in Murine 4T1 Breast Cancer Model

dc.contributor.authorDave Lumen
dc.contributor.authorSimo Näkki
dc.contributor.authorSurachet Imlimthan
dc.contributor.authorElisavet Lambidis
dc.contributor.authorMirkka Sarparanta
dc.contributor.authorWujun Xu
dc.contributor.authorVesa-Pekka Lehto
dc.contributor.authorAnu J. Airaksinen
dc.contributor.organizationfi=PET-keskus|en=Turku PET Centre|
dc.contributor.organizationfi=kemian laitos|en=Department of Chemistry|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.27622076134
dc.converis.publication-id45078187
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/45078187
dc.date.accessioned2022-10-28T13:45:09Z
dc.date.available2022-10-28T13:45:09Z
dc.description.abstractPolyethylene glycol (PEG) has been successfully used for improving circulation time of several nanomaterials but prolonging the circulation of porous silicon nanoparticles (PSi NPs) has remained challenging. Here, we report a site specific radiolabeling of dual-PEGylated thermally oxidized porous silicon (DPEG-TOPSi) NPs and investigation of influence of the PEGylation on blood circulation time of TOPSi NPs. Trans-cyclooctene conjugated DPEG-TOPSi NPs were radiolabeled through a click reaction with [In-111]In-DOTA-PEG(4)-tetrazine (DOTA = 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) and the particle behavior was evaluated in vivo in Balb/c mice bearing 4T1 murine breast cancer allografts. The dual-PEGylation significantly prolonged circulation of [In-111]In-DPEG-TOPSi particles when compared to non-PEGylated control particles, yielding 10.8 +/- 1.7% of the injected activity/g in blood at 15 min for [In-111]In-DPEG-TOPSi NPs. The improved circulation time will be beneficial for the accumulation of targeted DPEG-TOPSi to tumors.
dc.identifier.eissn1999-4923
dc.identifier.jour-issn1999-4923
dc.identifier.olddbid184076
dc.identifier.oldhandle10024/167170
dc.identifier.urihttps://www.utupub.fi/handle/11111/41549
dc.identifier.urnURN:NBN:fi-fe2021042823319
dc.language.isoen
dc.okm.affiliatedauthorAiraksinen, Anu
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.affiliatedauthorDataimport, 2609820 PET Tutkimus
dc.okm.discipline317 Pharmacyen_GB
dc.okm.discipline317 Farmasiafi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherMDPI
dc.publisher.countrySwitzerlanden_GB
dc.publisher.countrySveitsifi_FI
dc.publisher.country-codeCH
dc.relation.articlenumberARTN 686
dc.relation.doi10.3390/pharmaceutics11120686
dc.relation.ispartofjournalPharmaceutics
dc.relation.issue12
dc.relation.volume11
dc.source.identifierhttps://www.utupub.fi/handle/10024/167170
dc.titleSite-Specific In-111-Radiolabeling of Dual-PEGylated Porous Silicon Nanoparticles and Their In Vivo Evaluation in Murine 4T1 Breast Cancer Model
dc.year.issued2019

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
pharmaceutics-11-00686.pdf
Size:
3.12 MB
Format:
Adobe Portable Document Format
Description:
Publisher's version